Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 63.76M | 52.59M | 37.46M | 27.97M | 18.67M |
Gross Profit | 32.66M | 33.89M | 33.06M | 24.04M | 13.16M |
EBITDA | 3.52M | 7.30M | 8.93M | -4.21M | -928.00K |
Net Income | 1.93M | 4.51M | 5.64M | -4.05M | -642.00K |
Balance Sheet | |||||
Total Assets | 1.30B | 1.38B | 1.18B | 1.09B | 483.38M |
Cash, Cash Equivalents and Short-Term Investments | 146.32M | 422.14M | 344.85M | 387.92M | 106.81M |
Total Debt | 262.14M | 396.79M | 205.81M | 151.91M | 113.81M |
Total Liabilities | 1.02B | 1.09B | 904.64M | 952.40M | 434.49M |
Stockholders Equity | 285.16M | 281.90M | 279.48M | 141.00M | 48.88M |
Cash Flow | |||||
Free Cash Flow | 1.25M | 7.39M | 6.00M | -514.00K | -13.97M |
Operating Cash Flow | 1.39M | 7.59M | 6.32M | 624.00K | -13.55M |
Investing Cash Flow | 28.22M | -100.04M | -323.96M | 25.02M | 50.71M |
Financing Cash Flow | -73.45M | 181.54M | 102.22M | 109.82M | 43.39M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | 69.67M | 9.78 | 5.03% | 2.61% | 9.06% | -16.04% | |
58 Neutral | 79.99M | -49.98 | -4.57% | 3.34% | -0.03% | -126.57% | |
58 Neutral | 34.81M | 4.93 | 8.63% | 3.80% | 7.07% | 96.65% | |
49 Neutral | $67.50M | 158.72 | 0.22% | ― | 2.54% | -174.74% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
On August 21, 2025, Broadway Financial Corporation received a notification from Nasdaq regarding non-compliance with Listing Rule 5250(c)(1) due to the late filing of its Form 10-Q for the quarter ended June 30, 2025. The delay was attributed to the need for additional time to evaluate participation agreements for compliance with accounting standards. Nasdaq has given the company 60 days to submit a compliance plan, with the potential for an extension until February 16, 2026, if the plan is accepted. The company aims to file the Form 10-Q promptly to meet the deadline.
The most recent analyst rating on (BYFC) stock is a Hold with a $8.50 price target. To see the full list of analyst forecasts on Broadway Financial stock, see the BYFC Stock Forecast page.
On June 30, 2025, Broadway Financial Corporation held its Annual Meeting of Stockholders where several key decisions were made. The stockholders elected the nominees for the Board of Directors to serve until 2028, ratified the appointment of Crowe LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, approved the executive compensation on an advisory basis, and agreed to amend the Certificate of Incorporation to remove a provision regarding the removal of directors.